Estelle Chatelain

Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease

Violeta Raverdy, Federica Tavaglione, Estelle Chatelain et al. · Nature Medicine · 2024 · 134 citations · Full text

Medicine, Internal Medicine, Pathology +17

Data-driven subgroups of type 2 diabetes, metabolic response, and renal risk profile after bariatric surgery: a retrospective cohort study

Violeta Raverdy, Ricardo V. Cohen, Robert Caïazzo et al. · The Lancet Diabetes & Endocrinology · 2022 · 61 citations

Medicine, Endocrinology, Surgery +15

Performance of non-invasive tests for liver fibrosis resolution after bariatric surgery

Violeta Raverdy, Federica Tavaglione, Estelle Chatelain et al. · Metabolism · 2024 · 29 citations · Full text

Medicine, Pathology, Surgery +17

Combining diabetes, sex, and menopause as meaningful clinical features associated with NASH and liver fibrosis in individuals with class II and III obesity: A retrospective cohort study

Violeta Raverdy, Estelle Chatelain, Guillaume Lasailly et al. · Obesity · 2023 · 11 citations · Full text

Medicine, Endocrinology, Pathology +17

Subphenotype-Dependent Benefits of Bariatric Surgery for Individuals at Risk for Type 2 Diabetes

Leontine Sandforth, Violeta Raverdy, Arvid Sandforth et al. · Diabetes Care · 2025 · 11 citations · Full text

Medicine, Endocrinology, Surgery +17